Drugs / K-877-ER
last change Jun 2026 re-read 2 minutes ago

K-877-ER

Developed for
metabolic dysfunction-associated steatohepatitis
Investigated by
Kowa Research Institute, Inc.

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05327127 Nov 2022 → May 2026 metabolic dysfunction-associated steatohepatitis Kowa Research Institute, Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as K-877-ER ClinicalTrials.gov intervention name — accepted as the source's own label NCT05327127